Gainers

• rYojbaba (NASDAQ:RYOJ) shares rose 81.6% to $3.56 during Thursday's pre-market session. The market value of their outstanding shares is at $22.0 million.
• Agape ATP (NASDAQ:ATPC) stock increased by 71.78% to $3.59. The market value of their outstanding shares is at $2.0 million. The company's, Q1 earnings came out 4 days ago.
• Liminatus Pharma (NASDAQ:LIMN) shares moved upwards by 51.49% to $0.28. The company's market cap stands at $8.4 million.
• Sunshine Biopharma (NASDAQ:SBFM) shares rose 41.27% to $0.52. The company's market cap stands at $1.8 million.
• Quantum Cyber (NASDAQ:QUCY) stock increased by 20.36% to $3.96. The company's market cap stands at $41.1 million.
• Co-Diagnostics (NASDAQ:CODX) shares rose 18.82% to $2.84. The market value of their outstanding shares is at $8.6 million.

Losers

• Wellgistics Health (NASDAQ:WGRX) shares fell 22.4% to $0.1 during Thursday's pre-market session. The company's market cap stands at $16.3 million. As per the news, the Q1 earnings report came out 2 days ago.
• Cumberland Pharma (NASDAQ:CPIX) stock fell 17.18% to $4.58. The company's market cap stands at $82.8 million.
• HCW Biologics (NASDAQ:HCWB) stock declined by 15.64% to $2.05. The market value of their outstanding shares is at $16.3 million.
• Jaguar Health (NASDAQ:JAGX) stock fell 15.54% to $3.1. The market value of their outstanding shares is at $1.8 million. The company's, Q1 earnings came out yesterday.
• Silexion Therapeutics (NASDAQ:SLXN) stock fell 14.66% to $0.45. The market value of their outstanding shares is at $2.1 million. As per the news, the Q1 earnings report came out 4 days ago.
• Matinas BioPharma Hldgs (AMEX:MTNB) stock decreased by 10.37% to $0.57. The market value of their outstanding shares is at $4.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.